Now showing items 1-4 of 4

    • Solís, Yanahara; Álvarez, Ana M.; Fuentes, David; Barra, Daniela de la; Avilés, Carmen L.; Becker, Ana; Salgado, Carmen; Silva, Pamela; Topelberg, Santiago; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; Aedo Monsalve, Sócrates; Santolaya de Pablo, María Elena (2012)
      Introduction: To determine the etiology of invasive bacterial infection in high risk febrile neutropenia (HRFN) episodes in children with cancer is essential because of the favorable impact on mortality of the early empiric ...
    • Ducasse, Karen; Fernández, José P.; Salgado Muñoz, Carmen; Álvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Topelberg, Santiago; Tordecilla Cadiu, Juan; Varas P., Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; Santolaya de Pablo, María Elena (Sociedad Chilena de Infectología, 2014)
      Leukemia is the most common cancer in Chilean children. Acute lymphoblastic leukemia (ALL) is more prevalent and longer survival compared to acute myeloid leukemia (AML). Aims: To describe episodes of febrile neutropenia ...
    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Cofré, José; Enríquez, N.; O'Ryan Gallardo, Miguel; Payá, Ernesto; Salgado, Carmen; Silva, Pamela; Tordecilla, Juan; Varas P., Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela (2002)
      A risk prediction model for invasive bacterial infection (IBI) was prospectively evaluated among children presenting with cancer, fever, and neutropenia. The model incorporated assessment of 5 previously identified risk ...
    • Santolaya de Pablo, María Elena; Alvarez, Ana M.; Avilés, Carmen L.; Becker, Ana; Venegas, Marcela; O'Ryan Gallardo, Miguel; Salgado, Carmen; Topelberg, Santiago; Tordecilla, Juan; Varas, Mónica; Villarroel, Milena; Viviani, Tamara; Zubieta, Marcela; Maza León, Verónica de la; Vergara, Alejandra; Farfán, Mauricio J.; Torres Torretti, Juan Pablo (Lippincott Williams & Wilkins, 2013)
      Background: We previously created a risk prediction model for severe sepsis not clinically apparent during the first 24 hours of hospitalization in children with high-risk febrile neutropenia (HRFN), which identified 3 ...